Marker Therapeutics, Inc. (MRKR) › Shareholders' EquityMarker Therapeutics, Inc. (MRKR) — Shareholders' EquityAnnual figures by period end, from SEC filings.1999-12-31: $100.4K2000-12-31: $252.2K2001-12-31: -$74.0K2002-12-31: $465.8K2003-12-31: -$643.7K2004-12-31: -$2.44M2005-12-31: -$2.22M2006-12-31: -$3.00M2007-12-31: -$1.67M2008-12-31: -$3.02M2009-12-31: -$1.78M2010-12-31: -$3.87M2011-12-31: -$3.46M2012-12-31: -$6.04M2013-12-31: -$8.77M2014-12-31: -$1.02M2015-12-31: -$21.36M2016-12-31: $6.18M2017-12-31: $3.66M2018-12-31: $59.34M2019-12-31: $44.09M2020-12-31: $27.34M2021-12-31: $43.99M2022-12-31: $19.60M2023-12-31: $14.05M2024-12-31: $18.56M2025-12-31: $16.80M$16.80M1999-12-31Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31$16.80M-9.5%2026-03-18Balance as of period end2024-12-31$18.56M+32.1%2026-03-18Balance as of period end2023-12-31$14.05M-28.3%2026-03-18Balance as of period end2022-12-31$19.60M-55.4%2025-03-31Balance as of period end2021-12-31$43.99M+60.9%2024-03-26Balance as of period end2020-12-31$27.34M-38.0%2023-03-22Balance as of period end2019-12-31$44.09M-25.7%2022-03-17Balance as of period end2018-12-31$59.34M+1522.2%2021-03-09Balance as of period end2017-12-31$3.66M-40.9%2020-03-12Balance as of period end2016-12-31$6.18M—2019-03-15Balance as of period end2015-12-31-$21.36M—2018-03-23Balance as of period end2014-12-31-$1.02M—2017-03-14Balance as of period end2013-12-31-$8.77M—2016-04-14Balance as of period end2012-12-31-$6.04M—2015-04-15Balance as of period end2011-12-31-$3.46M—2013-05-15Balance as of period end2010-12-31-$3.87M—2012-04-16Balance as of period end2009-12-31-$1.78M—2012-04-16Balance as of period end2008-12-31-$3.02M—2012-04-16Balance as of period end2007-12-31-$1.67M—2012-04-16Balance as of period end2006-12-31-$3.00M—2012-04-16Balance as of period end2005-12-31-$2.22M—2012-04-16Balance as of period end2004-12-31-$2.44M—2012-04-16Balance as of period end2003-12-31-$643.7K-238.2%2012-04-16Balance as of period end2002-12-31$465.8K—2012-04-16Balance as of period end2001-12-31-$74.0K-129.4%2012-04-16Balance as of period end2000-12-31$252.2K+151.3%2012-04-16Balance as of period end1999-12-31$100.4K—2012-04-16Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)